Ligand profile
DH2
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_4546 — 2OG-Fe(II) oxygenase superfamily protein
Identifiers
Database identifiers and provenance.
- Ligand ID
DH2- PDB
1gp5- UniProt (similar protein)
Q96323- Target protein
- VK055_4546
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 127.5
- −1 ≤ LogP ≤ 5 1.19
- MW ≤ 500 Da 304.3
- LogP ≤ 5 1.19
- H-bond donors ≤ 5 5
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 1
- TPSA ≤ 140 Ų 127.5
Matches PAINS filter: catechol_A(92). May be a frequent false positive in HTS — review carefully.
Chemical representations
Canonical representations for cheminformatics workflows.
c1cc(c(cc1[C@H]2[C@@H](C(=O)c3c(cc(cc3O2)O)O)O)O)Oc1cc(c(cc1[C@H]2[C@@H](C(=O)c3c(cc(cc3O2)O)O)O)O)O
InChI=1S/C15H12O7/c16-7-4-10(19)12-11(5-7)22-15(14(21)13(12)20)6-1-2-8(17)9(18)3-6/h1-5,14-19,21H/t14-,15+/m1/s1InChI=1S/C15H12O7/c16-7-4-10(19)12-11(5-7)22-15(14(21)13(12)20)6-1-2-8(17)9(18)3-6/h1-5,14-19,21H/t14-,15+/m1/s1
CXQWRCVTCMQVQX-CABCVRRESA-NCXQWRCVTCMQVQX-CABCVRRESA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF03171
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand DH2 →
- PDB RCSB structure 1gp5 →
- UniProt UniProt Q96323 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “DH2”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_4546.
PDB 31
Ligands co-crystallized with this protein (structural evidence).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).